Estimating STn antigen may be useful for predicting the likelihood of lymph node metastasis or peritoneal dissemination and the clinical prognosis for patients with Borrmann type IV gastric carcinoma. This evidence concerns the gene EEF1A2 and metastatic malignant neoplasm in the lymph nodes.